Skip to main content

CORRECTION article

Front. Oncol., 27 September 2019
Sec. Pharmacology of Anti-Cancer Drugs
Volume 9 - 2019 | https://doi.org/10.3389/fonc.2019.00990
This article is part of the Research Topic Design and Application of Innovative Local Treatments in Glioblastoma and Other Cancers View all 12 articles

Corrigendum: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

This article is a correction to:

  1. RETRACTED: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

    1. Read original article
\nHanbo CaoHanbo Cao1Wenjun LiWenjun Li1Yizhou ZhouYizhou Zhou1Renxiang TanRenxiang Tan2Yue YangYue Yang1You ZhouYou Zhou1Qinglong Guo Qinglong Guo1*Li Zhao Li Zhao1*
  • 1State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing, China
  • 2State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, China

A Corrigendum on
Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

by Cao, H., Li, W., Zhou, Y., Tan, R., Yang, Y., Zhou, Y., et al. (2019). Front. Oncol. 9:188. doi: 10.3389/fonc.2019.00188

In the original article, there was a mistake in Figure 3H as published. Due to carelessness, the picture of the “k562-indo group” was accidentally placed in the “ku812-indo group”. The corrected Figure 3H appears below.

FIGURE 3
www.frontiersin.org

Figure 3.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: bone marrow environment, CXCL12/CXCR4, oroxylin A, Imatinib (IM), β-catenin/P-gp

Citation: Cao H, Li W, Zhou Y, Tan R, Yang Y, Zhou Y, Guo Q and Zhao L (2019) Corrigendum: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway. Front. Oncol. 9:990. doi: 10.3389/fonc.2019.00990

Received: 09 September 2019; Accepted: 16 September 2019;
Published: 27 September 2019.

Edited and reviewed by: Carmen Alvarez-Lorenzo, University of Santiago de Compostela, Spain

Copyright © 2019 Cao, Li, Zhou, Tan, Yang, Zhou, Guo and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qinglong Guo, anticancer_drug@163.com; Li Zhao, zhaoli@cpu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.